BENZACLIN 5 %
BENZOYL PEROXIDE : 5 % CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) : 1 % · DIN 02248472 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is BENZACLIN?
BENZACLIN 5 % contains BENZOYL PEROXIDE : 5 % CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02248472, held by BAUSCH HEALTH, CANADA INC., supplied as GEL for TOPICAL administration. Health Canada currently lists it as marketed, status dated 29-Mar-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is BENZACLIN used for?
Topical treatment of moderate acne vulgaris (Grade II to III). Not indicated for cystic acne (Grade IV).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02248472 |
|---|---|
| Brand name | BENZACLIN |
| Generic / active ingredient | BENZOYL PEROXIDE : 5 % CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) : 1 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 5 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D10AF51 CLINDAMYCIN, COMBINATIONS |
| AHFS class | 84:24.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Mar-2021 |
| Original market date | 2004-02-09 00:00:00 |
How is it administered?
Apply twice daily (morning and evening) to affected areas after gentle washing. Improvement may be seen in 2 weeks; up to 10 weeks may be required for best results.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15°C-25°C (before and after reconstitution). Do not freeze. Keep tightly closed. 3-month shelf life after mixing.
How is it supplied?
Dispensed in 50 g jar (after reconstitution of benzoyl peroxide gel and clindamycin phosphate powder).
Contraindications
Hypersensitivity to clindamycin, lincomycin, or any component; history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.
Warnings and precautions
For external use only. Risk of severe colitis/diarrhea (including pseudomembranous colitis). Minimize sunlight/UV exposure. Avoid contact with eyes and mucous membranes.
What can be used instead?
Other Canadian products sharing ATC code D10AF51 CLINDAMYCIN, COMBINATIONS. 6 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BIACNA TOPICAL GEL | 0.025 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02359685 |
| CABTREO | 3.1 % | Gel | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02550423 |
| CLINDOXYL ADV GEL | 3 % | GEL | GLAXOSMITHKLINE INC | MARKETED | DIN 02382822 |
| TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT | 5 % | GEL | TARO PHARMACEUTICALS INC | MARKETED | DIN 02464519 |
| TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL | 5 % | GEL | TARO PHARMACEUTICALS INC | MARKETED | DIN 02440180 |
| CLINDOXYL GEL | 1 % | GEL | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02243158 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.